BIONICHE LIFE SCIENCES Aktie

0,27 EUR -1,4599%

Zu Ihrem Onlinebroker

kaufen verkaufen

BIONICHE LIFE SCIENCES Aktienkurs : 08:08 ( 15 Min. verzögert)
0,270 € Letzter Kurs	-1,46% Veränderung	0,274 € Vortag	0,270 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,270 - 0,270 Tag	0,888 - 0,247 52 Wochen	0 Tag	4 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

BIONICHE LIFE SCIENCES Aktien…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

eResearch Issues Perspective on Bioniche Life Sciences Inc.

May 24, 2012 (ACCESSWIRE-TNW via COMTEX) -- Bioniche Life Sciences Inc. is a Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing world-wide of proprietary and innovative products...
14.05.

Bioniche burn rate rises on animal health spend

Efforts by Bioniche Life Sciences (ASX:BNC) to improve its bottom line by emphasising its animal health business are paying off in improved sales, but are...

09.05.

Bioniche Life Sciences Inc. Reports Q3, Fiscal 2012 Results

Bioniche Life Sciences Inc. (TOR:CA:BNC) (asx:BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the third quarter of its 2012 fiscal …
09.05.

Bioniche Life Sciences Inc. Reports Q3, Fiscal 2012 Results

BELLEVILLE, ON, May 9, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the third quarter of...
03.05.

Bioniche Life Sciences Inc Anxiously Waiting For Approval of Its Cost ...

As per recent reports, it has been proposed that Bioniche Life Sciences Inc is soon to bring into market its product ImmunocidinTM, which is termed to be an intratumoral treatment for mixed...